Page last updated: 2024-09-04

cyc 202 and Stroke

cyc 202 has been researched along with Stroke in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, JH; Hwang, IK; Kang, IJ; Kim, DW; Kim, IH; Kim, YM; Lee, CH; Lee, JC; Lee, TK; Lee, YL; Park, JH; Ryoo, S; Shin, BN; Won, MH1
Al Baradie, R; Alessandri, G; Ali, K; Bolton, D; Bosutti, A; Caccuri, F; Caruso, A; Krupinski, J; Kumar, S; Martinez-Gonzalez, J; Matou, S; Montaner, J; Pennucci, R; Petcu, EB; Qi, J; Rodriguez, C; Slevin, M; Tsai, LH1
Bach, S; Blevins, TL; Campbell, M; Meijer, L; Menn, B; Timsit, S1
Menn, B; Timsit, S1

Other Studies

4 other study(ies) available for cyc 202 and Stroke

ArticleYear
Down-regulation of cyclin-dependent kinase 5 attenuates p53-dependent apoptosis of hippocampal CA1 pyramidal neurons following transient cerebral ischemia.
    Scientific reports, 2019, 09-10, Volume: 9, Issue:1

    Topics: Animals; Apoptosis; CA1 Region, Hippocampal; Cyclin-Dependent Kinase 5; Ischemic Attack, Transient; Neuroprotection; Phosphorylation; Protein Transport; Pyramidal Cells; Retinoblastoma Protein; Roscovitine; Stroke; Tumor Suppressor Protein p53

2019
Targeting p35/Cdk5 signalling via CIP-peptide promotes angiogenesis in hypoxia.
    PloS one, 2013, Volume: 8, Issue:9

    Topics: Actin Cytoskeleton; Adaptor Proteins, Signal Transducing; Analysis of Variance; Blotting, Western; Cell Cycle Proteins; Cell Line; Cell Movement; Colorimetry; Cyclin-Dependent Kinase 5; Cytoskeleton; DNA Primers; Humans; Hypoxia; Immunoprecipitation; MEF2 Transcription Factors; Microarray Analysis; Microscopy, Fluorescence; Mutation, Missense; Neovascularization, Physiologic; Peptides; Pseudopodia; Purines; RNA Interference; Roscovitine; Signal Transduction; Stroke

2013
Delayed treatment with systemic (S)-roscovitine provides neuroprotection and inhibits in vivo CDK5 activity increase in animal stroke models.
    PloS one, 2010, Aug-12, Volume: 5, Issue:8

    Topics: Animals; Brain Ischemia; Cell Death; Chemistry, Pharmaceutical; Cyclin-Dependent Kinase 5; Disease Models, Animal; Drug Administration Routes; Humans; Injections; Male; Mice; Mitosis; Neuroprotective Agents; Purines; Rats; Roscovitine; Stroke; Time Factors

2010
Cyclin-dependent kinase inhibition with roscovitine: neuroprotection in acute ischemic stroke.
    Clinical pharmacology and therapeutics, 2012, Volume: 91, Issue:2

    Topics: Animals; Brain Ischemia; Clinical Trials as Topic; Cyclin-Dependent Kinases; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Models, Biological; Neuroprotective Agents; Protein Kinase Inhibitors; Purines; Roscovitine; Stroke

2012